Cargando…
Whole genome sequencing of 10K patients with acute ischaemic stroke or transient ischaemic attack: design, methods and baseline patient characteristics
BACKGROUND AND PURPOSE: Stroke is the second leading cause of death worldwide and the leading cause of mortality and long-term disability in China, but its underlying risk genes and pathways are far from being comprehensively understood. We here describe the design and methods of whole genome sequen...
Autores principales: | Cheng, Si, Xu, Zhe, Liu, Yang, Lin, Jinxi, Jiang, Yong, Wang, Yilong, Meng, Xia, Wang, Anxin, Huang, Xinying, Wang, Zhimin, Chen, Guohua, Wu, Songdi, Jia, Zhengchang, Chen, Yongming, Qiu, Xuerong, Wu, Jun, Song, Binbin, Ji, Weizhong, An, Zhongping, Xue, Wenjun, Zhao, Lili, Geng, Yu, Li, Hongyan, Li, Hao, Wang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258062/ https://www.ncbi.nlm.nih.gov/pubmed/33443231 http://dx.doi.org/10.1136/svn-2020-000664 |
Ejemplares similares
-
The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
por: Wang, Yongjun, et al.
Publicado: (2019) -
Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack
por: Zhou, Hongyu, et al.
Publicado: (2021) -
CO(2) combining power and outcomes in patients with acute ischaemic stroke or transient ischaemic attack
por: Wang, Anxin, et al.
Publicado: (2020) -
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019) -
Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry
por: Wang, Yongjun, et al.
Publicado: (2020)